Northeast Financial Consultants’s Immunogen Inc IMGN Stock Holding History

Northeast Financial Consultants’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-34,315	Closed	-$164K	–	357
2022 Q3	$164K	Hold	34,315	–	–	0.01%	318
2022 Q2	$154K	Hold	34,315	–	–	0.01%	316
2022 Q1	$163K	Hold	34,315	–	–	0.01%	373
2021 Q4	$255K	Hold	34,315	–	–	0.02%	306
2021 Q3	$195K	Hold	34,315	–	–	0.01%	335
2021 Q2	$226K	Hold	34,315	–	–	0.02%	326
2021 Q1	$278K	Hold	34,315	–	–	0.02%	282
2020 Q4	$221K	Hold	34,315	–	–	0.02%	296
2020 Q3	$124K	Hold	34,315	–	–	0.01%	295
2020 Q2	$158K	Hold	34,315	–	–	0.02%	280
2020 Q1	$117K	Hold	34,315	–	–	0.01%	256
2019 Q4	$175K	Hold	34,315	–	–	0.02%	296
2019 Q3	$83K	Hold	34,315	–	–	0.01%	316
2019 Q2	$74K	Hold	34,315	–	–	0.01%	323
2019 Q1	$93K	Hold	34,315	–	–	0.01%	312
2018 Q4	$165K	Buy	+34,315	New	+$208K	0.02%	147
2018 Q3	–	Sell	-34,315	Closed	-$333K	–	178
2018 Q2	$333K	Hold	34,315	–	–	0.1%	109
2018 Q1	$360K	Hold	34,315	–	–	0.12%	107
2017 Q4	$219K	Hold	34,315	–	–	0.07%	135
2017 Q3	$263K	Hold	34,315	–	–	0.1%	125
2017 Q2	$244K	Hold	34,315	–	–	0.1%	127
2017 Q1	$133K	Hold	34,315	–	–	0.06%	146
2016 Q4	$70K	Hold	34,315	–	–	0.03%	140
2016 Q3	$92K	Hold	34,315	–	–	0.04%	151
2016 Q2	$106K	Buy	34,315 +17,330	+102%	+$109K	0.05%	145
2016 Q1	$145K	Hold	16,985	–	–	0.08%	131
2015 Q4	$230K	Hold	16,985	–	–	0.12%	110
2015 Q3	$163K	Hold	16,985	–	–	0.08%	135
2015 Q2	$244K	Buy	+16,985	New	+$187K	0.11%	130

Other funds holding IMGN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Northeast Financial Consultants's IMGN Position: Q4 2022 in Review

Northeast Financial Consultants sold out of Immunogen Inc (IMGN) in Q4 2022, closing a stake of 34,315 shares — an estimated $164K sold.

Northeast Financial Consultants first reported a position in IMGN in Q2 2015 and held it in 29 quarters. The position peaked at $360K in Q1 2018. 204 funds tracked by Wall St. Rank hold IMGN as of Q4 2022.

Northeast Financial Consultants reported no remaining Immunogen Inc position as of Q4 2022 after selling out during the quarter.
Northeast Financial Consultants sold 34,315 Immunogen Inc shares in Q4 2022, an estimated $164K.
Northeast Financial Consultants first reported a position in Immunogen Inc in Q2 2015 and held it in 29 quarters.
Northeast Financial Consultants's Immunogen Inc position peaked at $360K in Q1 2018.
204 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2022.

Based on Northeast Financial Consultants's 13F filing for Q4 2022, filed 13 Feb 2023.